Certified by Founder Lodge
Cross-Border Impact Ventures
Canada - Toronto, Ontario
INVESTOR
1 Disclosed Funding Rounds $11,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cross Border Impact Ventures aims to be the preferred investor for transformative health technology companies with the potential of meeting the needs of women, children and adolescents across
| Company | Date | Round | Raised |
|---|---|---|---|
Daye |
October, 26 ,2022 | Series A | $11,500,000 |
OncoLens |
July, 17 ,2023 | Unknown | |
Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
Daye
OncoLens
Raydiant Oximetry, Inc.
Oxford Cancer Analytics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)